ANZUU — Envoy Medical Cashflow Statement
0.000.00%
- $71.70m
- $74.26m
Annual cashflow statement for Envoy Medical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|
Period Length: | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | 10-K | 10-K |
Standards: | USG | USG | USG |
Status: | Final | Final | Final |
Net Income/Starting Line | -0.001 | -0.252 | 19.2 |
Non-Cash Items | — | -4.45 | -24.9 |
Unusual Items | |||
Other Non-Cash Items | |||
Changes in Working Capital | 0.001 | 1.46 | 3.03 |
Change in Prepaid Expenses | |||
Change in Accounts Payable | |||
Change in Accrued Expenses | |||
Change in Taxes Payable | |||
Cash from Operating Activities | 0 | -3.24 | -2.66 |
Other Investing Cash Flow Items | — | -425 | 1.12 |
Change in Net Investments | |||
Cash from Investing Activities | — | -425 | 1.12 |
Financing Cash Flow Items | — | -9.13 | 0 |
Other Financing Cash Flow | |||
Net Issuance / Retirement of Stock | |||
Net Issuance / Retirement of Debt | |||
Cash from Financing Activities | 0.025 | 428 | 1.5 |
Beginning Cash Balance | |||
Ending Cash Balance | |||
Net Change in Cash | 0.025 | 0.125 | -0.042 |